Breaking AI & Tech News Analyzed

Footage captured on the streets of Tehran shows small groups of citizens gathering around Enghelab Square – a historic rally point for pro‑regime supporters – some waving Iranian flags, others draped over their backs. The atmosphere is far from uniform; debates and arguments erupted shortly after the ceasefire announcement, reflecting a spectrum of emotions from shock to tentative hope.The video, posted by Majid Nouri – son of former prison official Hamid Nouri – includes his running commentary. He notes that the discussions began around 3 a.m. and continued into the morning, with participants expressing both anger and disbelief. "In no way do we trust America," Nouri declared, echoing a sentiment he says is shared by virtually every Iranian.Pro‑government demonstrators were heard chanting "Death to America, death to Israel, death to compromisers!" and burning U.S. and Israeli flags, according to the Associated Press. The chants persisted despite attempts by organizers to calm the crowd, underscoring the depth of anti‑Western feeling among hardliners.While the ceasefire halted active hostilities, the war has already claimed at least 1,900 lives in Iran. With internet services largely blacked out, gauging the broader public mood is challenging, but pockets of Tehran reported subdued celebrations in the early hours of Wednesday.Local resident Ali, a 31‑year‑old, summed up the prevailing uncertainty: "Most people here don’t trust the US and still don’t know exactly what is going to happen, so they are unsure whether they should be happy or worried." He warned that the ceasefire’s two‑week duration offers no guarantee of lasting peace.Business owners are beginning to test the waters. Hamid, a 43‑year‑old shopkeeper whose grocery and cleaning‑supplies store closed after the February bombings, said, "Today feels like there is no war," and he has reopened his shop, hoping to recover lost income for his family.Iranian officials are framing the pause as a diplomatic victory. Former foreign minister Ali Akbar Velayati posted on X that the conflict has reshaped the global power balance, positioning Iran within a new multipolar order. President Masoud Pezeshkian praised the ceasefire as the fruit of the blood of Iran’s “great martyred leader” and the collective will of the people.Strategically, the ceasefire highlights Tehran’s ability to disrupt the vital Strait of Hormuz, a chokepoint for global oil shipments. Analysts note that this leverage could bolster Iran’s negotiating stance, even as former U.S. President Donald Trump previously warned that a full‑scale clash would threaten "a whole civilisation." As sunrise illuminated the capital, daily life resumed with shops reopening and traffic returning to the streets, yet the prevailing mood remains a blend of exhaustion, cautious optimism, and lingering mistrust of the United States.

Tens of thousands of people have been hired by Scale AI – a firm 49% owned by Meta – to train artificial‑intelligence models by scraping Instagram accounts, harvesting copyrighted artwork and transcribing pornographic soundtracks, according to the Guardian.Scale AI promotes its Outlier platform as a flexible, expert‑driven marketplace, recruiting professionals from medicine, physics and economics to "become the expert that AI learns from."Workers, however, say the reality diverges sharply from high‑level model refinement. They describe tasks that involve massive personal‑data scraping and content that many find morally uncomfortable.Outlier is managed by Scale AI, which holds contracts with the U.S. Pentagon and other defense companies. Its chief executive, Alexandr Wang, is hailed by Forbes as the world’s youngest self‑made billionaire, while former managing director Michael Kratsios served as science adviser to former President Donald Trump.One contractor noted that users of Meta platforms would be shocked to learn their photos and friends’ images are being harvested for AI training, with workers manually reviewing profiles to extract data.The Guardian interviewed ten Outlier contributors – many also journalists, graduate students, teachers or librarians – who took the gig work out of economic desperation. One said, "A lot of us were really desperate" and felt compelled to accept the unstable, low‑pay assignments.These gig workers, dubbed “taskers,” often feel they are training their own replacements, expressing “internalised shame and guilt” over contributing to the automation of creative professions.Law firm Clarkson, representing AI gig workers, estimates that hundreds of thousands of people worldwide now labor on platforms like Outlier. Taskers report bait‑and‑switch recruitment tactics, where advertised high salaries are replaced by lower‑paid projects after onboarding.All contributors are monitored through a tool called Hubstaff, which can screenshot browsers to verify work. While Scale AI claims the software is only for accurate payment, workers describe it as constant surveillance.Assignments have ranged from transcribing pornographic audio and labeling photos of dead animals or dog faeces, to annotating diagrams of infant genitalia and violent police scenarios. One doctoral student recounted being promised “no nudity” only to receive explicit porn clips.Scale AI says it shuts down any task flagged as inappropriate and does not accept projects involving child sexual‑abuse material or pornography, though workers note that publicly available images of minors have been used for training.Social‑media scraping tasks required workers to tag individuals by name, location and age, sometimes pulling data from accounts of users under 18. One task asked contributors to order Facebook photos by the subject’s age, prompting ethical unease.In addition to personal data, taskers were asked to harvest copyrighted artwork, with strict instructions to avoid AI‑generated images and select only hand‑drawn pieces. Scale AI maintains it does not ask workers to violate copyright standards.Scale AI’s client list includes major tech firms such as Google, Meta and OpenAI, as well as the U.S. Department of Defense and the government of Qatar, highlighting the growing demand for labelled data as AI models scale.Some workers reported interacting with ChatGPT and Claude, and speculated they might be training Meta’s upcoming model, code‑named “Avocado.”OpenAI announced it ended its partnership with Scale AI in June 2025, citing its supplier code of conduct that mandates ethical treatment of all workers.Despite irregular pay, occasional mass layoffs and the unsettling nature of many tasks, many taskers remain on the Outlier platform, hoping the AI future will eventually improve conditions. One said, "I have to be positive about AI because the alternative is not great."In response, a Scale AI spokesperson stated, "Outlier provides flexible, project‑based work with transparent pay. Contributors choose when and how they participate, and we regularly hear from highly skilled contributors who value the flexibility and opportunity to apply their expertise on the platform."

On a sun‑lit picnic beside Canberra’s Molonglo River, a tartan blanket, a bottle of wine, crusty baguette, cheese and a daring chicken‑and‑grape salad from a gourmet magazine marked the beginning of a romance that would be defined by food.Their shared appetite for culinary experimentation quickly turned into a series of kitchen showdowns—debates over meat doneness, oven temperatures, seasoning ratios and the eternal butter‑vs‑oil dilemma. While the clashes were frequent, the meals they produced together often became celebrated triumphs.Over the years, their lives were chronicled in the spines of recipe books and the aromas of countless dinners. From the quest for the perfect loaf to the fiery sting of chilies that left a lasting impression, each dish mapped the highs and lows of their partnership.He gravitated toward savoury mains; she honed a talent for desserts. Their culinary quirks—her habit of returning leftovers to the fridge, his ritual of swaddling roasted meat in tea towels—added both friction and flavor to their shared table.Even after their separation, the couple’s kitchen remains a shared space. A well‑worn ceramic baking tray, scarred by years of roasting turkeys, chickens and lamb, still serves as the foundation for gravy‑making and other culinary rituals during holiday gatherings.One of his most enduring contributions is a dish they call Pasta Dimanche. Born from a pantry raid on a Sunday night, the pasta blends diced capsicum, carrot, purple onion, garlic, celery, parsley and tomato with a tin of tuna, cracked pepper, salt and a splash of Tabasco and green chilli sauce. The result is a vibrant, summery plate that celebrates colour, texture and the surprise harmony of warm and crisp.Recipe: Pasta Dimanche (Serves 4)Ingredients:1 red onion, finely chopped1 carrot, finely diced3 garlic cloves, finely chopped1 yellow capsicum, finely chopped1 green capsicum, finely chopped1 red capsicum, finely chopped1 cup finely chopped parsley370 g tin tuna, drained1 tsp Tabasco1 tsp green TabascoDried pasta of choice (to serve)Method:1. Toss the vegetables, garlic, parsley and tuna in a large bowl; season with Tabasco, salt and pepper.2. Cook pasta in salted boiling water until al dente; drain.3. Divide pasta among four bowls, top with the tuna‑vegetable mix, and serve.Despite their split, they continue to exchange food news, recipe links from the New York Times, and tips on premium ingredients—proving that a shared love of cooking can outlast even the most intimate of relationships.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The UK medicines regulator has opened an inquiry into a growing number of clinics that sell injectable peptides while promoting them as cures for everything from ageing to injury recovery. The investigation, disclosed by the Guardian, focuses on whether these businesses are breaching the Human Medicines Regulations 2012 by making unauthorised medicinal claims. Interest in peptide‑based treatments has surged in recent years, driven by social‑media influencers, some healthcare professionals, and direct‑to‑consumer marketers. Yet the scientific foundation for most of these claims is weak, with the bulk of research confined to animal models or cell‑culture studies. According to an MHRA spokesperson, any clinic that advertises a peptide as having therapeutic benefits must treat the product as a medicine, which triggers a comprehensive regulatory framework. "If clinics offering peptide injections make medicinal claims for those treatments, the products will be considered medicines and subject to regulation," the agency warned, adding that it will act against any identified breaches. Guardian reporters identified several high‑ranking Google search results that list peptides such as Cortexin (promoted for neuroprotection), BPC‑157 (claimed to aid tissue repair), and Thymosin Alpha (advertised to boost immunity). After being contacted, one clinic removed the statements from its website. Another clinic, while acknowledging the limited human evidence, continued to market seven specific peptides, providing price lists (£350 per month for a single peptide, £450 for two) and offering delivery via vials, syringes, or pre‑filled pens for an additional fee. During a free consultation, a clinician highlighted the experimental nature of the products, noting the absence of large‑scale, randomised clinical trials and recommending a break of four to eight weeks between treatment cycles to mitigate unknown risks. The clinician suggested BPC‑157 for post‑exercise recovery, describing it as a facilitator of cellular repair and blood flow, but warned against its use in smokers or individuals with a family history of cancer due to potential angiogenic effects. The second peptide discussed was MOTS‑C, portrayed as a mitochondrial enhancer that could improve stress resilience, lower insulin resistance, and reduce visceral fat by boosting cellular energy production (ATP). The MHRA confirmed it is reviewing whether the clinician’s statements constitute medicinal claims. The clinic defended its approach, emphasizing that it clearly informs clients that the peptides are not licensed medicines and that the evidence base is largely pre‑clinical. In a broader statement, Lynda Scammell, head of borderline products at the MHRA, explained that peptide products may be marketed as cosmetics, supplements, or medicines, and each case is assessed on its intended use, pharmacological effect, and supporting evidence. She added, "We disregard claims that products are for ‘research purposes’ if it is clear that such claims are being used as an attempt to avoid medicines regulations." Peptides are short chains of amino acids, some of which occur naturally (e.g., insulin). While synthetic peptide analogues like semaglutide and tirzepatide have secured approval for weight‑loss treatments, many of the compounds promoted by these clinics remain experimental and lack the rigorous safety and efficacy testing required for medicinal products.

Bosnia and Herzegovina's national football team has made history by qualifying for the 2026 World Cup after a thrilling penalty shootout victory over Italy at the iconic Bilino Polje Stadium in Zenica. The match ended 1-1 after extra time, with Bosnia emerging victorious in the shootout.The Bilino Polje Stadium, known for its intimidating atmosphere for visiting teams, lived up to its reputation as thousands of Bosnian fans descended upon the arena, creating a cauldron-like environment that fueled the team's performance. The stadium's compact nature and close proximity of fans made it feel like a home game for the Bosnian team.The Bosnian fans began arriving in Zenica in the early hours of the morning, dressed in the team's colors and waving the national flag. The city was transformed into a giant stage, with convoys of cars laden with fans, draped with the flag and blaring horns, turning Zenica into a sea of celebration.The historic bond between Bosnia and Italy was also on display, as Bosnia's legendary captain, Edin Dzeko, asked fans to applaud the Italian national anthem before kickoff, referencing the Italian team's visit to Sarajevo in 1996 following the Bosnian war.The win sparked jubilation across the country, with nearly 100,000 supporters gathering in Sarajevo to celebrate what many termed one of the greatest wins in the nation's history. The players and coaching staff were greeted as heroes, and the victory was seen as a reminder of the team's strength and resilience.

‘Your Friends & Neighbours’ returns for a second season that doubles down on its deliciously dark satire of the ultra‑rich enclave of Westport, New York – a thinly veiled stand‑in for Westchester’s high‑finance playground. The series remains a “rich dessert” of a show: indulgent, a little unhealthy, but undeniably moreish.Jon Hamm reprises Andrew “Coop” Cooper, a former Manhattan hedge‑fund star who now survives by burgling the opulent homes of his equally extravagant neighbours. Coop’s charisma is built on a blend of oak‑like steadiness and a perpetual tumbler of $500 whisky, allowing him to charm both victims and collaborators. Unlike Don Draper’s secret shame, Coop’s anxiety is a quieter, more comedic driver that fuels the season’s caper.Season two opens with Coop, now approaching fifty, injuring his back while rifling a mansion’s study. The mishap forces him to rely on his longtime lookout Elena (Aimee Carrero) and brings a new, reluctant ally into the fold. Meanwhile, the arrival of the flamboyant billionaire Owen (James Marsden) rattles the delicate Westport ecosystem, adding fresh tension to the criminal enterprise.The narrative also shifts focus to the personal toll of wealth. Coop’s ex‑wife Mel (Amanda Peet) navigates perimenopause and the looming emptiness of her children leaving for college, while their daughter Tori (Isabel Gravitt) deliberately flunks a Princeton interview, railing against the university as a “engine of rigged, corrosive capitalism.” This scene underscores the show’s satirical edge, reminding viewers that the glittering excess is built on fragile foundations.Despite its glossy façade, the series offers unexpected emotional depth. Hamm and Peet convey a wistful sadness that resonates beyond the bank‑balance zeros, suggesting that middle‑aged ex‑lovers remain bound by past mistakes. The season balances heist thrills with moments of genuine heart, positioning the show as a guilty‑pleasure dramedy that “gets away with it.”Your Friends & Neighbours is currently streaming on Apple TV+.

Tottenham's new head coach, Roberto De Zerbi, has issued an apology for his previous comments on Mason Greenwood, the Marseille forward who faced charges of attempted rape and assault in 2022. De Zerbi faced backlash from fan groups, including Proud Lilywhites, Women of the Lane, and Spurs Reach, due to his remarks about Greenwood. In his first interview with Tottenham's in-house media, De Zerbi stated, 'I have never wanted to downplay the issue of violence against women or violence against anyone more broadly.' He emphasized his commitment to standing up for vulnerable individuals and expressed regret for any offense caused by his previous statements. 'I am sorry if I offended anyone's feeling with this subject matter – I have a daughter and I'm very sensitive to these things, and I always have been.' Greenwood was charged in October 2022 but the charges were dropped in February 2023 due to a lack of witnesses and new evidence. He has since joined Marseille and denied the allegations. De Zerbi's appointment as Tottenham's head coach was met with criticism from the Tottenham Hotspur Supporters' Trust, who expressed 'serious and far-reaching concerns' over his comments on Greenwood.

The United States Supreme Court issued an 8‑1 decision on Tuesday that invalidated Colorado’s law prohibiting “conversion therapy” for LGBTQ minors. The majority held that the ban infringed on the First Amendment’s free‑speech guarantees, arguing that even therapeutic dialogue falls under protected expression. Justice Elena Kagan wrote that when a state suppresses one side of a debate while supporting the other, the constitutional issue is “straightforward.” In contrast, Justice Neil Gorsuch emphasized that the First Amendment “stands as a shield against any effort to enforce orthodoxy in thought or speech.” Only Justice Ketanji Brown Jackson dissented, warning that the ruling “threatens to impair states’ ability to regulate the provision of medical care” and underscored the documented harms of conversion therapy to LGBTQ youth. Colorado’s 2019 statute barred any “practice or treatment” aimed at changing a child’s gender identity or sexual orientation, though it allowed discussion of religion, gender, and sexuality. No individual has yet been sanctioned under the law. The case was brought by Christian counselor Kaley Chiles, who argued that the ban prevented her from offering voluntary, faith‑based talk therapy, a position backed by the administration of former President Donald Trump. Approximately two dozen states have enacted similar bans, reflecting a growing consensus that conversion therapy is both ineffective and harmful. Scientific studies link the practice to higher rates of depression and suicidal ideation among LGBTQ individuals. Major medical associations have condemned it as a dangerous, discredited intervention. Advocates for LGBTQ rights criticized the Court’s ruling as a setback. Polly Crozier, director of family policy at GLAD Law, said, “This is a dangerous practice that has been condemned by every major medical association in the country. Today’s decision does not change the science, and it does not change the fact that conversion therapists who harm patients will still face legal consequences.” The decision is expected to make enforcement of existing bans more difficult, potentially prompting a wave of legal challenges in other jurisdictions that have sought to protect LGBTQ youth from conversion therapy.